Cardiol Therapeutics (CRDL.TO) Q3 2026 Earnings

13AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.12
-0.1
-0.07
-0.05

Details

Expected EPS
-0.09478364843903998
Actual EPS
-0.049025856
Surprise EPS
0.05
Surprise Percent
+48.28%

Description

Cardiol Therapeutics (CRDL.TO) has reported earnings of -0.049025856 per share for Q3 2026.

0 Comments

Share your thoughts